Detalles de la búsqueda
1.
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Br J Cancer
; 119(9): 1075-1085, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30353045
2.
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer.
Gynecol Oncol
; 146(3): 484-490, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698009
Resultados
1 -
2
de 2
1
Próxima >
>>